Pyxis Oncology, Inc.
PYXS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$77 | -$74 | -$121 | -$76 |
| Dep. & Amort. | $3 | $2 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $6 |
| Stock-Based Comp. | $13 | $17 | $16 | $6 |
| Change in WC | -$12 | -$12 | $5 | $7 |
| Other Non-Cash | $16 | -$4 | $10 | $21 |
| Operating Cash Flow | -$58 | -$71 | -$89 | -$35 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$7 | -$6 | -$1 |
| Net Acquisitions | $0 | $7 | $0 | -$0 |
| Inv. Purchases | -$160 | -$197 | $0 | -$0 |
| Inv. Sales/Matur. | $169 | $92 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | $8 | -$105 | -$6 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $59 | $6 | $0 | $152 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $0 | $152 |
| Financing Cash Flow | $59 | $6 | $0 | $304 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $10 | -$170 | -$96 | $268 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11 | $181 | $276 | $8 |
| End Cash | $21 | $11 | $181 | $276 |
| Free Cash Flow | -$58 | -$77 | -$96 | -$36 |